HIGHLIGHTS
- who: Paolo Cameli et al. from the Respiratory Unit, University of Milan-Bicocca, SGerardo Hospital, Monza, Italy have published the research: Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres, in the Journal: Life 2022, 1149 of /2022/
- what: The aim of this study was to describe the features of a multicentric population of patients who developed an ILD during treatment with ICIs. The study has several weaknesses: due to its retrospective nature, the risk of referral and reporting bias is significant, despite the considerable experience of these . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.